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ABSTRACT 
The molecular pathways that control Helicobacter pylori (Hp)-associated inflammatory reac-
tion are complex, but locally induced cytokines and virulence factors seem to have a major 
role in maintaining the ongoing inflammation. Therefore this study was aimed to evaluate the 
association of the virulence factors of Hp and gastric mucosal interleukin-17/23 mRNA ex-
pression in dyspeptic patients. 
Mucosal IL-17 and IL-23 mRNA expression in H. pylori infected and non-infected gastric 
biopsies were determined by real-time RT-PCR. Virulence factors, vac-A and cag-A were 
evaluated using PCR. 
There was no significant difference in mucosal IL-17 and IL-23 mRNA expression between 
H. pylori infected and non-infected patients. Their expression in mucosa did not correlate 
with chronic gastritis and chronic active gastritis. IL-17 and IL-23 mRNA expression in mu-
cosa of patients with vacA m1 were significantly higher than those observed in patients with 
vacA m2. The severity of polymorphonuclear infiltration and chronic active gastritis was 
higher in cag-A positive than cag-A negative patients. 
H. pylori infections carrying the vacA m1 allele have higher IL-17 and IL-23 mRNA and the 
current study suggests that the virulence factor vacA allele’s m1 are important for the severe 
gastric inflammation. 
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INTRODUCTION 
H pylori is a spiral-shaped Gram-
negative flagellate bacterium that colonizes 
the gastric mucosa of approximately 50 % 
of the world's population. Although its col-
onization often stays asymptomatic, but can 
progress into gastric or duodenal ulcers, 
gastric malignancies and mucosa-associated 
lymphoid tissue lymphomas (Fox and 
Wang, 2007). Hp-associated inflammatory 
reaction is defined by a massive mucosal 
infiltration of polymorphonuclear leuko-
cytes (PMN), T cells, macrophages, and 
plasma cells (Avilés-Jiménez et al., 2012). 
The ability of Hp to cause disease is 
thought to attribute to complex interplay 
between host genetic factors, environmental 
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and bacterial factors. H. pylori adheres to 
the cells of gastric epithelial and secretes 
effector molecules that can change gastric 
epithelial cell function and viability (Ernst 
and Gold, 2000; Chatterjee et al., 2012). 
These changes enhance  production of cy-
tokines, which are involved in gastric in-
flammation and epithelial cell damage 
(Avilés-Jiménez et al., 2012). Moreover, 
Hp infection elicits a noticeable mucosal 
accumulation of T lymphocytes, which is 
responsible to gastric pathology by synthe-
sizing T helper (Th) 1-type cytokines, such 
IFN-γ and TNF-α  (D'Elios et al., 1997; 
Ernst and Gold, 2000; Hitzler et al., 2012). 
Recently, a novel pathway of inflammation 
characterized by excessive production of 
IL-17 has been reported to be involved in 
the pathogenesis of immune-mediated dis-
eases, such as rheumatoid arthritis, experi-
mental autoimmune encephalomyelitis, and 
psoriasis (Kolls and Linden, 2004; 
Steinman, 2007). IL-17 consists of a family 
of related cytokines (IL-17A–F), IL-17- 
producing cells termed Th17 cells. These 
cells also produce TNF-α, IL-6, IL-22, and 
granulocyte macrophage-colony stimulating 
factor (Kolls and Linden, 2004; Park et al., 
2005; Steinman, 2007; Weaver et al., 
2007). IL-17 stimulates the synthesis of IL-
1β, IL-6, TNF-α, PGE2, ICAM-1 and cy-
clo-oxygenase-2 (Fossiez et al., 1998; 
Griffin et al., 2012; Serelli-Lee et al., 
2012). Thus, IL-17 seems to provide a link 
between T cell activation and inflammatory 
responses. In spite of marked Th 
(Placeholder 1) cell response, Hp-colonized 
gastric mucosa also contains high levels of 
IL-17 (Luzza et al., 2000; Mizuno et al., 
2005). The synthesis of IL-8 by gastric 
mononuclear and epithelial cells is positive-
ly regulated by IL-17, thus emphasizing the 
potential role of IL-17 in the Hp-driven in-
flammation (Luzza et al., 2000). However, 
the factors involved in the control of IL-17 
production in Hp-associated gastritis are yet 
unclear.  
IL-23 is a heterodimeric protein that is 
composed of a specific IL-23p19 subunit 
and IL-12p40 subunit. This cytokine is pri-
marily produced by activated dendritic 
cells, monocytes and macrophages (Opp-
mann et al., 2000). IL-23/p19-null mice 
have reduced numbers of Th17 cells, thus 
confirming the role of IL-23 in enhancing 
IL-17 production (Ghilardi et al., 2004). 
The clinical outcome of H. pylori infection 
is suggested to be linked to certain strains 
such as the cytotoxin-associated gene 
(cagA) and vacuolating cytotoxin (vacA). 
The cagA gene which is a marker for the 
presence of a Pathogenicity Island 
(CagPAI), has been shown to be involved 
in induction of proinflammatory chemokine 
released. 
The vacA gene has a mosaic structure 
and comprised signal (s) and middle (m) 
regions (Stathis et al., 2009). The s region 
consists of any one of four signal sequences 
(type s1a, s1b, s1c or s2), while the m re-
gion consists of two middle region alleles 
(type m1 or m2) (Stathis et al., 2009). The 
s1 subtype and m1 subtype have been 
linked to more severe clinical manifestation 
(Dong et al., 2008; Ferrand et al., 2008; 
Kuo et al., 2008; Stathis et al., 2009). CagA 
is present in more than 50 % of the H. pylo-
ri strains and encodes the cagA protein. It is 
a marker of the presence of the Pathogenici-
ty Island, (Swisher and Barbati, 2007; De 
Luca et al., 2008) is related to virulence of 
the H. pylori strain and is associated with 
peptic ulcer and gastric malignancy in some 
populations. This study was aimed to eval-
uate the association of the virulence factors 
of Hp and gastric mucosal interleukin-17/23 
mRNA expression in dyspeptic patients. 
 
MATERIALS AND METHODS 
A total of 58 H. pylori-infected gastritis 
patients 23 men (43.43 ± 3.53) and 35 
women (40.57 ± 2.44) were participated in 
this study. Hp infection was determined by 
the rapid urease test, PCR 16srRNA, urea 
and histological examination of biopsies 
taken from the corpus. Patients were classi-
fied as Hp-infected only if the three tests 
were positive, respectively. Four biopsies 
were collected from 58 Hp-infected, and 
used for rapid urease test, histological ex-
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amination, assessment of bacterial virulence 
factors, detection of H. pylori and cytokine 
RNA analysis. 
 
Histological examination 
Sections of biopsy specimens were em-
bedded 10 % buffered formalin and stained 
with hematoxylin and eosin to examine gas-
tritis and with giemsa to detect Hp. The his-
tological severity of gastritis was blindly 
graded from normal to severe based on the 
degree of mononuclear cell (MNC) and 
polymorphonuclear leukocyte (PMN) infil-
tration, and atrophy according to the Updat-
ed Sydney system (Manxhuka-Kerliu et al., 
2009) on a four-point scale: 0, no; 1, mild; 
2, moderate; and 3, severe changes. 
 
PCR amplification 
DNA for polymerase chain reaction 
(PCR) was extracted using the Bioflux tis-
sue (Bioflux, Japan). Oligonucleotide pri-
mers for PCR amplification of specific 
segments are shown in Table 1. For vacA 
and cagA evaluation, the PCR program 
comprised 35 cycles of denaturation (at 94 
°C for 30 s), annealing (at 56 °C for 30 s, 
extension at 72 °C for 30 s), and one final 
extension (at 72 °C for 5 min).  
 
 
Quantitative analyses for IL-17 and IL-23 
mRNA in the gastric mucosa using real-
time RT-PCR 
Total RNA was isolated from whole 
gastric biopsy specimens using total RNA 
extraction biozol (bioflux, Japan). An ali-
quot containing 0.2 μg of total RNA was 
used for the reverse transcription reaction, 
which was conducted using the Superscript 
first-strand cDNA synthesis system (Fer-
mentas, Finland) according to the manufac-
turer’s instructions. The sequences of oli-
gonucleotide primer and probe are shown in 
Table 2. The quantification of IL-17 and 
IL-23 mRNA levels was performed using a 
Rotor-Gene 3000 (Corbett).  Q-PCR reac-
tions were performed in a total volume of 
25 μl containing 3 μl of synthesized cDNA 
solution, 12.5 μl of 2x Rotor-Gene Probe 
PCR Master Mix (Qiagen, Germany), 
500 nM of each primer and 250 nM of the 
TaqMan probe. Amplification program in-
cluded a pre warming step (10 min at 
94 ºC), denaturation step (94 °C for 15 s) 
and an annealing/extension step (60 °C for 
60 s). β-actin was quantified as a reference 
gene to normalize the mRNA expression 
levels of other genes. The relative quantifi-
cation of gene expression in each sample 
was analyzed by the 2ΔΔCt method and ex-
pressed as the ratio of related gene to β-
actin mRNA. 
 
 
 
Table 1: PCR primers for amplification of cagA and vacA 
ReferencesSize of PCR 
product (bp) 
Primer sequence Primer  
designation 
 
(Kim et al., 2013) 567 bp (m1) 
642 bp (m2) 
vacAmF: 5'-CAATCTGTCCAATCAAGCGAG-3' 
vacAmR: 5'-GCGTCTAAATAATTCCAAGG-3' 
vacA m1/m2 
(Roesler et al., 
2011) 
259 bp (s1) 
286 bp (s2) 
 
VA1-F: 5'-ATGGAAATACAACAAACACAC-3' 
VA1-R: 5'-CTGCTTGAATGCGCCAAAC-3' 
vacA s1/s2 
(Rasmussen et al., 
2012) 
232 bp Cag1:  5-ATGACTAACGAAACTATTGATC-3 
Cag2:  5-CAGGATTTTTGATCGCTTTATT-3 
CagA 
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Table 2: Primer and probe sequences employed in this study 
Gene Primer and probe sequence  
β-actin Forward  5-AGCCTCGCCTTTGCCGA-3 
 Reverse 5-CTGGTGCCTGGGGCG-3 
 Probe FAM-CCGCCGCCCGTCCACACCCGCC-TAMRA 
IL-17A Forward  5-AATCTCCACCGCAATGAGGA-3 
 Reverse  5-ACGTTCCCATCAGCGTTGA-3 
 Probe  FAM-CGGCACTTTGCCTCCCAGATCACA-TAMRA 
IL-23(p19) Forward  5-TCAGTGCCAGCAGCTTTCAC-3 
 Reverse 5-TCTCTTAGATCCATGTGTCCCAC-3 
 Probe FAM-CTCTGCACACTGGCCTGGAGTGCA-TAMRA 
 
 
 
Statistical analysis 
All experiments were performed at least 
three times. Parametric data are presented 
as mean and SE and nonparametric data are 
presented as medians (25–75 % quartiles). 
Statistical analysis was performed by 
Mann-Whitney Rank Sum test or nonpaired 
t test depending on the data set. A p value 
of <0.05 was accepted as statistically signif-
icant. 
 
RESULTS 
Effect of virulence factors in H. pylori-
infected on the Mucosal IL-17 and IL-23 
mRNA levels in gastric mucosa 
In our study, no significant differences 
were observed between the expression of 
interleukin 17 and 23 in Helicobacter pylori 
positive and negative patients (Figure 1). 
Our results showed that in H. pylori infect-
ed patients; mucosal IL-17 and IL-23 
mRNA levels were dependent on the vacA 
(m1 and m2) status. Mucosal IL-17 and IL-
23 mRNA expression in gastritis patients 
with vacA (m1)-positive were significantly 
higher than those observed in gastritis pa-
tients with vacA (m2) – positive (Figure 2). 
Mucosal IL-17 and IL-23 mRNA expres-
sion in gastritis patients with vacA (s1m1)-
positive was also significantly higher than 
those observed in gastritis patients with va-
cA (s1m2)-positive (Figure 3). Also no sig-
nificant differences were observed between 
the expression of interleukin 17 and 23 in 
gastritis patients with cagA–positive and 
cagA-negative (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mucosal IL-17 and IL-23 mRNA ex-
pression in gastritis patients. RNA was extract-
ed from gastric biopsies of 58 Hp-infected pa-
tients, 50 Hp non-infected patients with gastritis 
and analyzed for IL-17 and IL-23 by real time 
PCR. Levels are normalized to β-actin. Values 
are presented as mean ± SD of all experiments. 
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Figure 2: Mucosal IL-17 and IL-23 mRNA expression in gastritis patients with vacA-positive. RNA was 
extracted from gastric biopsies of 14 Hp-infected patients with vacA (m1)-positive, 30 Hp-infected pa-
tients with vacA (m2)-positive with gastritis and analyzed for IL-17 and IL-23 by real time PCR. Levels 
are normalized to β-actin. Values are presented as mean ± SD of all experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Mucosal IL-17 and IL-23 mRNA expression in gastritis patients with vacA-positive. RNA was 
extracted from gastric biopsies of 14 Hp-infected patients with vacA (s1m1)-positive, 30 Hp-infected 
patients with vacA (s1m2)-positive with gastritis and analyzed for IL-17 and IL-23 by real time PCR. 
Levels are normalized to β-actin. Values are presented as mean ± SD of all experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Mucosal IL-17 and IL-23 mRNA expression in Hp-infected patients with cagA-positive and 
cagA-negative. RNA was extracted from gastric biopsies of 37 Hp-infected patients with cagA-positive, 
21 Hp-infected patients with cagA-negative and analyzed for IL-17 and IL-23 by real time PCR. Levels 
are normalized to β-actin. Values are presented as mean ± SD of all experiments. 
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Correlation between virulence factors and 
gastric mucosal inflammation and types of 
disease 
Severe polymorphonuclear infiltration 
and chronic gastritis were significantly 
higher in gastritis patients with vacA (m1)-
positive compare to those observed in gas-
tritis patients with vacA (m2)-positive. Se-
vere polymorphonuclear infiltration and 
chronic active gastritis were also signifi-
cantly higher in gastritis patients with 
cagA-positive compared to those observed 
in gastritis patients with cagA-negative pa-
tients (Table 3).  
 
Correlation between Mucosal IL-17 and 
IL-23 mRNA levels and gastric mucosal 
inflammation and types of disease 
In those infected with H. pylori, IL-17 
and IL-23 mRNA expression in mucosa did 
not correlate with the degree of mononucle-
ar (P=0.192 and P=0.471) or polymorpho-
nuclear (P=0.279 and P=0.628) cell infiltra-
tion, chronic gastritis (P=0.192 and 
P=0.471), or chronic active gastritis 
(P=0.279 and P=0.628) assessed by the 
Sydney system. 
 
DISCUSSION 
In this study we aimed to evaluate the 
association of the virulence factors of Hp 
and gastric mucosal interleukin-17/23 
mRNA expression in patients with gastritis. 
Our results showed that there was no signif-
icant difference between the expression of 
interleukin 17 and 23 in Helicobacter pylori 
positive and negative patients. That might 
be related to the presence of gastritis in two 
groups. The results of the present study 
showed that mucosal IL-17 and IL-23 
mRNA expression were dependent on the 
vacA (m1) status and their expression in 
patients infected with vacA m1-positive 
strains were significantly higher than those 
observed in patients with vacA m2-positive 
strains. Until now a similar study has not 
been done and this is the first report about 
correlation of vacA with IL-17 and IL-23 
expression. 
 
 
 
Table 3: Relationship between histological parameters determined in gastric biopsy specimens and 
virulence factors 
Genotype No. Monoculear 
iflitration** 
Polymorphonuclear 
infiltration 
Chronic  
gastritis 
Chronic ac-
tive gastritis 
cagA (+) 37 1.62 (1-3) 0.94 (1-3) 1.62 (1-3) 0.94 (1-3) 
cagA (-) 21 1.88 (1-3) 0.44 (1-3) 1.88 (1-3) 0.44 (1-3) 
P*  0.424 0.046 0.424 0.046 
vacA 
m1 
m2 
 
12 
36 
 
2.08 (1-3) 
1.56 (1-3) 
 
0.58 (1-3) 
0.86 (1-3) 
 
2.08 (1-3) 
1.56 (1-3) 
 
0.58 (1-3) 
0.86 (1-3) 
P*  0.034 0.433 0.034 0.433 
s1 
s2 
38 
7 
1.71 (1-3) 
1.57 (1-3) 
0.79 (1-3) 
0.57 (1-3) 
1.71 (1-3) 
1.57 (1-3) 
0.79 (1-3) 
0.57 (1-3) 
P*  0.708 0.202 0.708 0.202 
s1m1 14 2.08 (1-3) 0.58 (1-3() 2.08 (1-3) 0.58 (1-3) 
s1m2 25 1.50 (1-3) 0.92 (1-3) 1.50 (1-3) 0.92 (1-3) 
s2m1 0     
s2m2 9 1.57 (1-3) 0.57 (1-3) 1.57 (1-3) 0.57 (1-3) 
P*  0.099 0.222 0.099 0.222 
*Median scores were compared with the Mann–Whitney test. 
**The histopathological parameters were scored as: 0, none; 1, mild; 2, moderate; 3, severe 
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In this study, we determined that the 
expression of interleukin 17 and 23 in all 
patients was high. It has been reported that 
the IL-23–IL-17 axis plays an important 
role in the development of chronic inflam-
mation and in host defenses against bacteri-
al infection (Gisbert and Calvet, 2011; Kuo 
et al., 2011; Nakamura et al., 2012). Also 
vacuolating activity is higher in s1/m1 gen-
otypes than in s1/m2 genotypes, and is ab-
sent in s2/m2 genotypes (Ota et al., 2009; 
Suzuki et al., 2009; Park et al., 2010). 
Therefore, it can be concluded that vacA 
s1/m1 strains cause more immune response 
and are more frequently associated with 
gastritis.  
Considering that expression of interleu-
kins 17 and 23 in patients with vacA m1 
exists in chronic gastritis, therefore, the 
overexpression of these interleukins along 
with vacA m1 may similarly lead to chronic 
gastritis. In our study, the relationships be-
tween cagA-positive and severe polymor-
phonuclear infiltration and chronic active 
gastritis were significantly higher than 
those observed in patients with cagA-
negative. While in Western countries it has 
been demonstrated that more severe gastric 
inflammation develops after infection with 
cagA-positive strains and in Asian countries 
there is no such difference (Umit et al., 
2009; Rathbone and Rathbone, 2011). 
It has been reported that in Western 
countries, cagA-positive status has been 
associated with the severe outcomes of the 
infection (Kondo et al., 2009; Lehours et 
al., 2009; Zullo et al., 2009). It is possible 
that the relationship between H. pylori gen-
otypes and infection with gastric inflamma-
tory response varies in different nations. 
These variations in the clinical consequenc-
es are due to factors such as duration of the 
infection, inflammatory response of the pa-
tient, virulence of H. pylori strains, etc. 
Although our results do not support the cor-
relation of IL-17 and IL-23 with the in-
flammatory phenotype of H. pylori infected 
patients, but emerging experimental evi-
dence suggests that IL-23/IL-17 pathway is 
an important dynamic force for existing 
gastric inflammation in H pylori-infected 
patients. However, further studies are need-
ed to establish the exact contribution of 
each of these cytokines in the H pylori-
associated gastric pathology. 
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